Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna. . That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size The future of US stocks fell on Wednesday morning, as Wall Street was concerned about continuing tensions between the US and China, as well as continuing fears about the coronavirus and the cost it has affected. to the economy. On the US-China front, tensions escalated after the US …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »
BioNTech BNTX Shares, + 3.95% and Pfizer Inc. PFE, + 1.46% Both were launched into pre-market trade on Monday after companies said their experimental COVID-19 vaccine elicited a T-cell response in people participating in a phase 1/2 clinical trial in Germany. The vaccine candidate also again demonstrated that it can …
Read More »